PPA
CCXI

Parametric Portfolio Associates’s ChemoCentryx, Inc. CCXI Stock Holding History

Parametric Portfolio Associates’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6.11M Sell
243,610
-23,150
-9% -$651K ﹤0.01% 1715
2021
Q4 		$9.71M Buy
266,760
+6,710
+3% +$236K 0.01% 1406
2021
Q3 		$4.45M Buy
260,050
+115,062
+79% +$1.79M ﹤0.01% 1914
2021
Q2 		$1.94M Buy
144,988
+79,245
+121% +$1.95M ﹤0.01% 2458
2021
Q1 		$3.37M Buy
65,743
+13,718
+26% +$825K ﹤0.01% 2439
2020
Q4 		$3.22M Sell
52,025
-29,844
-36% -$1.71M ﹤0.01% 2364
2020
Q3 		$4.49M Buy
81,869
+2,320
+3% +$125K ﹤0.01% 1974
2020
Q2 		$4.58M Buy
79,549
+38,444
+94% +$2.09M ﹤0.01% 1936
2020
Q1 		$1.65M Buy
41,105
+1,808
+5% +$76.8K ﹤0.01% 2507
2019
Q4 		$1.55M Buy
+39,297
New +$690K ﹤0.01% 2842
2019
Q3 		– Sell
-57,809
Closed -$538K – 4026
2019
Q2 		$538K Buy
57,809
+2,319
+4% +$26.8K ﹤0.01% 3334
2019
Q1 		$771K Buy
+55,490
New +$635K ﹤0.01% 3151
2018
Q3 		– Sell
-11,900
Closed -$157K – 3982
2018
Q2 		$157K Buy
+11,900
New +$142K ﹤0.01% 3744
2016
Q3 		– Sell
-34,422
Closed -$155K – 3811
2016
Q2 		$155K Buy
34,422
+22,815
+197% +$85.6K ﹤0.01% 3666
2016
Q1 		$29K Buy
11,607
+798
+7% +$2.91K ﹤0.01% 3945
2015
Q4 		$88K Sell
10,809
-249
-2% -$1.76K ﹤0.01% 3869
2015
Q3 		$67K Sell
11,058
-299
-3% -$2.16K ﹤0.01% 3226
2015
Q2 		$93K Sell
11,357
-128
-1% -$1.02K ﹤0.01% 3884
2015
Q1 		$87K Buy
11,485
+151
+1% +$1.18K ﹤0.01% 3876
2014
Q4 		$77K Sell
11,334
-25,074
-69% -$133K ﹤0.01% 3925
2014
Q3 		$164K Sell
36,408
-17,846
-33% -$94.3K ﹤0.01% 3658
2014
Q2 		$317K Buy
54,254
+32,600
+151% +$183K ﹤0.01% 3491
2014
Q1 		$144K Buy
21,654
+4,634
+27% +$32.2K ﹤0.01% 3695
2013
Q4 		$99K Buy
+17,020
New +$87.8K ﹤0.01% 3728

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Parametric Portfolio Associates's CCXI Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its ChemoCentryx, Inc. (CCXI) stake by 8.7% in Q1 2022, selling an estimated $651K and leaving 243,610 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1715.

Parametric Portfolio Associates first reported a position in CCXI in Q4 2013 and has held it in 24 quarters since. The position peaked at $9.71M in Q4 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Parametric Portfolio Associates held 243,610 shares of ChemoCentryx, Inc. worth $6.11M as of Q1 2022.
  • Parametric Portfolio Associates sold 23,150 ChemoCentryx, Inc. shares in Q1 2022, an estimated $651K.
  • ChemoCentryx, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1715 holding.
  • Parametric Portfolio Associates first reported a position in ChemoCentryx, Inc. in Q4 2013 and has held it in 24 quarters since.
  • Parametric Portfolio Associates's ChemoCentryx, Inc. position peaked at $9.71M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.